Biocon Ltd. NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

338.80 -1.35 (-0.40%)

443.9K

NSE+BSE Volume

NSE 30 Sep, 2025 1:19 PM (IST)

Biocon Ltd. share price target

Biocon Ltd. has an average share price target of 367.20. The consensus estimate represents an upside of 8.38% from the last price of 338.80. View 9 reports from 5 analysts offering long-term price targets for Biocon Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	30 Sep 2025	Biocon	Consensus Share Price Target	338.80	380.11	-	12.19	buy	pdf Detailed Estimates
	13 Aug 2023	Biocon	ICICI Securities Limited Reco Target	338.80	230.00	256.20 (32.24%)	Target met	Sell	pdf post cache		Broker Report Chasing growth at cost of margins ICICI Securities Limited Biocon’s Q1FY24 performance was dragged by the biologics biz. Profitability of the segment was under pressure owing higher rebates in Fulphila (USD 15mn). Segmental PBT dropped 600bps QoQ to 1.6% in Q1FY24. US market share of Fulphila and Ogivri expanded by 200bps and 100bps QoQ to 16% and 11%, and stable at 12% for bGlargine. pdf Copy Link Share on Share on Share on Share on Alert
	29 May 2023	Biocon	Sharekhan Reco	338.80	266.00	245.20 (38.17%)	Target met	Hold	pdf post cache		Broker Report Biocon Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2023	Biocon	ICICI Securities Limited Reco Target	338.80	250.00	243.00 (39.42%)	Target met	Hold	pdf post cache		Broker Report Tepid organic growth ICICI Securities Limited Biocon Limited’s (Biocon) Q4FY23 performance was boosted by consolidation of the acquired business of biosimilars (segment revenue up 114% YoY) from Viatris. Reported gross margin was inflated by ~150bps and EBITDA margin by 360bps due to licensing income of Rs1.75bn. pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2023	Biocon	Axis Direct	338.80	260.00	239.85 (41.25%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct Current TP: Rs 260/share (Earlier TP: Rs 260/share) pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2023	Biocon	ICICI Direct Target	338.80	235.00	239.85 (41.25%)	Target met	Hold	pdf post cache		Broker Report Biocon ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2023	Biocon	Motilal Oswal Target	338.80	260.00	243.00 (39.42%)	Target met	Neutral	pdf post cache		Broker Report 4Q - A miss; efforts underway to build growth levers across segments Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	09 Mar 2023	Biocon	Geojit BNP Paribas Target	338.80	238.00	223.85 (51.35%)	Target met	Hold	pdf post cache		Broker Report BIOCON LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	20 Feb 2023	Biocon	AUM Capital	338.80	260.00	227.70 (48.79%)	Target met	Neutral	pdf post cache		Broker Report Biocon Ltd AUM Capital pdf Copy Link Share on Share on Share on Share on Alert
	16 Feb 2023	Biocon	Axis Direct Target	338.80	260.00	242.85 (39.51%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct Recommendation: We maintain HOLD on the stock pdf Copy Link Share on Share on Share on Share on Alert
	16 Feb 2023	Biocon	ICICI Direct Target	338.80	230.00	242.85 (39.51%)	Target met	Hold	pdf post cache		Broker Report Biocon ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners